Skip to main content
. Author manuscript; available in PMC: 2024 Dec 2.
Published in final edited form as: Circ Cardiovasc Interv. 2012 Feb 7;5(1):77–81. doi: 10.1161/CIRCINTERVENTIONS.111.963405

Figure 1.

Figure 1.

The frequency of death, myocardial infarction and stroke at one year with clopidogrel vs. aspirin in patients on, and not on, a calcium channel blocker at study entry. It can be seen that patients on calcium channel blockers had a higher event rate, but the risk reduction associated with clopidogrel was actually greater in such patients.